Suchergebnisse - "Antolin, Albert A"

PubPharm (46)

11

canSAR : update to the cancer translational research and drug discovery knowledgebase

enthalten in: Nucleic acids research | 2023

von di Micco, P. | Antolin, A. | Mitsopoulos, C. | +10

12

Identification of differential polypharmacology between the PARP inhibitor rucaparib and its major metabolite

enthalten in: bioRxiv.org | 2022

von Hu, H. | Serra, C. | Llebaria, A. | +1

13

canSAR chemistry registration and standardization pipeline

enthalten in: Journal of cheminformatics | 2022

von Dolciami, D. | Villasclaras-Fernandez, E. | Kannas, C. | +3

14

canSAR chemistry registration and standardization pipeline

enthalten in: Journal of cheminformatics | 2022

von Dolciami, D. | Villasclaras-Fernandez, E. | Kannas, C. | +3

15

canSAR chemistry registration and standardization pipeline

enthalten in: Journal of cheminformatics | 2022

von Dolciami, D. | Villasclaras-Fernandez, E. | Kannas, C. | +3

16

Rare Variation in Drug Metabolism and Long QT Genes and the Genetic Susceptibility to Acquired Long QT Syndrome

enthalten in: Circulation. Genomic and precision medicine | 2022

von Gray, B. | Baruteau, A. | Antolin, A. | +23

17

Identification of different side effects between PARP inhibitors and their polypharmacological multi‐target rationale

enthalten in: British Journal of Clinical Pharmacology | 2022

von Sandhu, D. | Antolin, A. | Cox, A. | +1

18

Identification of different side effects between PARP inhibitors and their polypharmacological multi-target rationale

enthalten in: British journal of clinical pharmacology | 2022

von Sandhu, D. | Antolin, A. | Cox, A. | +1

19

Evolution of kinase polypharmacology across HSP90 drug discovery

enthalten in: bioRxiv.org | 2021

von Antolin, A. | Clarke, P. | Collins, I. | +2

20

Coronavirus canSAR – a Data-Driven, AI-Enabled, Drug Discovery Resource for the Research Community

enthalten in: chemRxiv.org | 2021

von Mitsopoulos, C. | Antolin, A. | Villasclaras Fernandez, E. | +9